Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000181911 | SCV000234214 | likely benign | not provided | 2021-05-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19716085, 28988457) |
Invitae | RCV001088304 | SCV000543432 | likely benign | Long QT syndrome | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987996 | SCV001137539 | benign | Long QT syndrome 2 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001841744 | SCV001356093 | uncertain significance | Cardiac arrhythmia | 2023-01-03 | criteria provided, single submitter | clinical testing | This missense variant replaces valine with methionine at codon 1038 of the KCNH2 protein. Computational prediction tools and conservation analyses are inconclusive regarding the impact of this variant on protein structure and function. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in an individual referred for long QT testing (PMID: 19716085). This variant has been identified in 20/175942 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The relatively high frequency of this variant in the general population suggests that this variant is unlikely to be disease-causing. However, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001804794 | SCV002051248 | likely benign | not specified | 2021-12-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003894913 | SCV004714113 | likely benign | KCNH2-related condition | 2023-10-12 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV001088304 | SCV004835855 | uncertain significance | Long QT syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing | This missense variant replaces valine with methionine at codon 1038 of the KCNH2 protein. Computational prediction tools and conservation analyses are inconclusive regarding the impact of this variant on protein structure and function. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in an individual referred for long QT testing (PMID: 19716085). This variant has been identified in 20/175942 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The relatively high frequency of this variant in the general population suggests that this variant is unlikely to be disease-causing. However, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004019015 | SCV005033313 | benign | Cardiovascular phenotype | 2023-09-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Cardiovascular Biomedical Research Unit, |
RCV000058199 | SCV000089719 | not provided | Congenital long QT syndrome | no assertion provided | literature only | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. |